Abcellera Biologics Inc (ABCL) — Net Asset Quality Index
Abcellera Biologics Inc (ABCL) has a Net Asset Quality Index of 84.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.36 Billion minus total liabilities of $215.59 Million yields net assets of $1.14 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check ABCL financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Abcellera Biologics Inc Net Asset Quality Index Over Time (2018–2025)
This chart shows how Abcellera Biologics Inc's Net Asset Quality Index has evolved across 8 annual periods from 2018 to 2025. As of December 2025, the index stands at 84.1%, representing net assets of $1.14 Billion against total assets of $1.36 Billion USD. See working capital to net assets of Abcellera Biologics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Abcellera Biologics Inc (2018–2025)
The table below presents the year-by-year Net Asset Quality Index for Abcellera Biologics Inc from 2018 to 2025, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Abcellera Biologics Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.1% | $1.14 Billion | $1.36 Billion | $215.59 Million | ▲ +6.5 pp |
| 2024 | 77.6% | $1.06 Billion | $1.36 Billion | $304.47 Million | ▲ +0.2 pp |
| 2023 | 77.4% | $1.15 Billion | $1.49 Billion | $335.78 Million | ▼ -2.6 pp |
| 2022 | 80.0% | $1.23 Billion | $1.54 Billion | $307.63 Million | ▲ +2.2 pp |
| 2021 | 77.8% | $1.03 Billion | $1.32 Billion | $292.84 Million | ▼ -4.8 pp |
| 2020 | 82.6% | $830.51 Million | $1.01 Billion | $175.03 Million | ▲ +38.9 pp |
| 2019 | 43.6% | $10.25 Million | $23.49 Million | $13.24 Million | ▼ -10.4 pp |
| 2018 | 54.0% | $11.61 Million | $21.49 Million | $9.88 Million | — |